![]() |
Volumn 1, Issue 3, 2009, Pages 182-187
|
Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
C REACTIVE PROTEIN;
HEPTANOIC ACID DERIVATIVE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPID;
PYRROLE DERIVATIVE;
AGED;
ANKLE BRACHIAL INDEX;
ARTICLE;
BIOASSAY;
BLOOD;
BLOOD PRESSURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST OF ILLNESS;
DIABETIC FOOT;
DOSE RESPONSE;
FEMALE;
FOOT;
HUMAN;
LEUKOCYTE COUNT;
LIVER FUNCTION TEST;
MALE;
METABOLISM;
MIDDLE AGED;
PATHOLOGY;
PHYSIOLOGY;
PILOT STUDY;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
WOUND HEALING;
AGED;
ANKLE BRACHIAL INDEX;
BLOOD PRESSURE;
C-REACTIVE PROTEIN;
COST OF ILLNESS;
DIABETIC FOOT;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENDPOINT DETERMINATION;
FEMALE;
FOOT;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LEUKOCYTE COUNT;
LIPIDS;
LIVER FUNCTION TESTS;
MALE;
MIDDLE AGED;
PILOT PROJECTS;
PYRROLES;
RECURRENCE;
WOUND HEALING;
|
EID: 78649522705
PISSN: None
EISSN: 17530407
Source Type: Journal
DOI: 10.1111/j.1753-0407.2009.00031.x Document Type: Article |
Times cited : (26)
|
References (0)
|